1/52
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Postpartum
6 weeks after delivery regardless of route of delivery or outcome
Postpartum assessmnet
Assessment, provide comfort and support, identifying signs of complications, promoting health education
Pregnancy-induced hypervolemia
Increased blood volume during pregnancy to support fetal development and maternal needs
Diuresis/Diaphoresis, fluid volume loss
Increased urine output and sweating as the body returns to pre-pregnancy state
Growth in size and vascularity to the uterus
Increased blood flow to the uterus to support the fetus; uterus grows to the size of a large watermelon
Large wound at placental site
About the size of a dinner plate; risk for infection, hemorrhage
Regrowth of endometrial lining; sloughing of decidual tissue
Endometrial lining regenerates after childbirth, accompanied by shedding of decidual tissue
Hormonal changes (Estrogen, Progesterone, Prolactin, Oxytocin)
Occur after childbirth, influence breastfeeding, recovery, and uterine involution
Increased coagulability and venous stasis
Put women at risk for blood clots, embolisms; makes fluid in body harder to move back to upper part of the body
Decrease in diaphragm pressure
Results in increased abdominal pressure, affects respiratory mechanics
Return of immune system to normal
Resumes its pre-pregnancy function, helps protect the body against infections and disease
Perineal trauma
Damage that occurs during childbirth, can lead to pain and complications during recovery
Reduced tone of abdominal muscles
Can lead to decreased core stability and potential issues with posture and movement
Decreased GI motility
Can result in constipation and discomfort during the postpartum period
Blood pressure
Systolic 90-140, diastolic 50-90
Pulse
50-110
Respirations
12-20
Temperature
<100.4˚F
SPO2
≥95
Pain
Subjective, variable, influences affect
Standard prenatal labs
Type and screen, CBC, CMP (maybe), hepatitis B & C, HIV, rubella, RPR serology, GBS
Type and screen
Blood type and Rh factor
CBC
RBC, platelets, WBC, HgB
CMP
Comprehensive medical panel; screens for electrolytes, kidney and liver function
RPR serology
Screens for syphilis
GBS
Screens for group Beta strep, a natural vaginal flora bacteria
BUBBLELE assessment
Breasts, uterus, bowel, bladder, lochia, episiotomy/lacerations, lower extremities, emotions
Involution
Return of the uterus to the pelvic cavity
Teratogens
Agents, such as chemicals and viruses, that can reach the embryo or fetus during prenatal development and cause harm
Breastfeeding breasts assessment
Inspect and palpate for signs of engorgement (tenderness, firmness, warmth, enlargement), proper latch, adequate emptying, expected changes
Non-breastfeeding breasts assessment
Assess for primary engorgement, inspect and palpate for signs of engorgement (tenderness, firmness, warmth, enlargement), no breast/nipple stimulation, ice, no expression
Expected breast assessment findings
Soft and nontender in first 24 hours pp, slightly firm and nontender on pp day 2, firm, tender, and warm to touch on pp day 3
Uterus assessment
Always use both hands to assess to prevent uterine prolapse, assess for location, position, and tone of the fundus (boggy/firm), encourage voiding before assessment so bladder does not move uterus away from midline
Expected uterus findings
Uterus is midline, below the umbilicus, and firm
Bowel assessment
Assess bowel sounds, constipation, hemorrhoids; administer stool softeners as needed; educate on fluid and fiber intake, activity
Bladder assessment
Assist to the bathroom and encourage voiding within 2 to 4 hours postbirth, measure urinary output postbirth (at least 300 mL within 2 to 4 hours of delivery), assess for frequency, urgency, and burning on urination
Lochia assessment
Assess color, amount (scant, light, moderate, or heavy), odor (fleshy odor, smells similar to menstrual blood) clots (occur when lochia has been pooling in the lower uterine segment)
Episiotomy/lacerations assessment
Assessed with fundus and lochia in post-delivery period; assessed every shift using REEDA (redness, edema, ecchymosis, discharge, approximation of edges of episiotomy or laceration)
Episiotomy
Surgical incision of the perineum to enlarge the vagina and facilitate delivery during childbirth
Lower extremities
Assess for venous thrombosis, calves and groin area for tenderness, edema, and warmth each shift, compare pulses in both extremities, mild edema can be normal in first 2-3 days as long as equal bilaterally and not worsening
Emotional state
Assess mood and affect related to circumstances, support or lack of, provide education on postpartum blues
Pain management medications
Tylenol (Acetaminophen), Motrin (Ibuprofen), Oxycodone (Roxicodone), Vicodin (Acetaminophen/Hydrocodone), Percocet (Acetaminophen/Oxycodone), dermoplast spray
Bleeding control medications
Pitocin (Oxytocin)
Other supportive medications
Tucks pads (Witch Hazel), Colace or Pericolace, prenatal vitamins, iron supplements, simethicone (gas pill)
Tdap vaccine
Offered during pregnancy to build fetal antibodies, if did not receive during pregnancy, offer postpartum
Rhogam
Given if mother is Rh – and baby is Rh +, given within 72 hours postpartum (IM)
Bonding
Taking in phase, taking hold phase, letting go phase; en face positioning, calls baby by name, dresses/undresses baby, feeds baby, responds to baby’s cry, rooming in, assuming responsibility for infant care
Taking in phase
Taking hold phase
Letting go phase
Cesarean delivery considerations
Wound, pain, anesthesia (spinal vs. general), foley catheterization, decreased GI motility, decreased mobility, impaired self-care and infant-care, mental and emotional impact if not planned; increased risk for pph, venous thrombolytic events (DVT/PE), pp infections
Discharge teaching
Warning signs, pelvic rest, self care, medication management/side effects, contraception, activity, rest/comfort
Postpartum follow up appointments
All patients get a comprehensive assessment and depression screening at 4 to 6 weeks, high risk patients follow up with primary OB provider at 1 week (or 2 weeks)